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Primary aldosteronism (PA) is a common form of endocrine hypertension that is 
characterized by the excessive production of aldosterone relative to suppressed plasma 
renin levels. PA is usually caused by either a unilateral aldosterone-producing adenoma or 
bilateral adrenal hyperplasia. Somatic mutations have been identified in several genes that 5 
encode ion pumps and channels that may explain the aldosterone excess in over half of 
aldosterone-producing adenomas, whereas the pathophysiology of bilateral adrenal 
hyperplasia is largely unknown. A number of mouse models of hyperaldosteronism have 
been described that recreate some features of the human disorder although none replicate 
the genetic basis of human PA. Animal models that reproduce the genotype-phenotype 10 
associations of human PA are required to establish the functional mechanisms that underlie 
the endocrine autonomy and deregulated cell growth of the affected adrenal and for 
preclinical studies of novel therapeutics. Herein, we discuss the differences in adrenal 
physiology across species and describe the genetically-modified mouse models of PA that 






Primary aldosteronism (PA) is the most common form of endocrine hypertension 
characterized by the excessive production of aldosterone relative to suppressed plasma 20 
renin and is associated with an increased risk of cardiovascular and cerebrovascular 
complications (1-2). PA is predominantly caused by either of two main subtypes: unilateral 
aldosterone excess due to an aldosterone-producing adenoma or bilateral aldosterone 
excess caused by bilateral adrenal hyperplasia. Unilateral PA is treated by adrenalectomy 
whereas patients with bilateral PA are usually treated pharmacologically with a 25 
mineralocorticoid receptor antagonist (3).  
Major advances have been made in our understanding of the pathogenesis of 
aldosterone-producing adenomas with the discovery of somatic mutations in a number of 
genes that can explain the overproduction of aldosterone in over half of patients with a 
unilateral aldosterone-producing adenoma. The affected genes encode ion pumps and 30 
channels (KCNJ5, ATP1A1, ATP2B3 and CACNA1D) or key players in the control of cell growth 
(CTNNB1 and PRKACA) (4). Mutations in several of the affected genes (KCNJ5, ATP2B3, 
CACNA1D) have been shown to cause an increase in intracellular Ca2+ concentration that 
results in an increase in transcription of the aldosterone synthase gene (CYP11B2) via the 
activation of Ca2+ signaling (5-7). In contrast, mutations in ATP1A1 (Na+/K+-ATPase 1-35 
Leu104Arg and Val332Gly) result in intracellular acidification that may cause the 
overproduction of aldosterone (8). The pathogenesis of bilateral adrenal hyperplasia, 
however, remains obscure mainly because molecular studies are hampered due to the 
limited availability of resected adrenal specimens from patients with bilateral adrenal 




Animal models of PA would be useful to study mechanisms that control cell growth 
and autonomous aldosterone production and for preclinical testing of novel therapeutics. In 
this review, we discuss adrenal physiology in different animal species and describe the 
currently available mouse models of hyperaldosteronism. 
Physiology of the adrenal gland in different species 45 
The human adrenal cortex comprises 3 morphologically distinct zones, the zona 
glomerulosa (zG), zona fasciculata (zF) and zona reticularis (zR) that have specific functional 
properties for the production of mineralocorticoids, glucocorticoids and androgens, 
respectively (referred to as “functional zonation”). In the normal human adrenal gland, the 
restricted synthesis of aldosterone in the zG and of cortisol in the zF is due to the adrenal 50 
expression of CYP11B2 exclusively in the zG for aldosterone synthesis and the expression of 
CYP17 and CYP11B1 in the zF for cortisol production (9, 10) (Figure 1).  
The adrenal cortices of pigs, dogs and cattle are similarly functionally organized to 
those of humans with aldosterone biosynthesis restricted to cells of the zG and cortisol 
production in the zF. Mice display a different morphological zonation compared to humans. 55 
The CYP17 gene encoding 17α-hydroxylase and 17,20-lyase is not expressed in mice, as in 
other rodents, and therefore mice produce corticosterone instead of cortisol and do not 
synthesize adrenal androgens. A functional zR is thus absent in mice and this zone is difficult 
to distinguish histologically (Figure 1, Table 1).  
The adrenals of young mice have a layer of juxtamedullary cortical cells (the X-zone) 60 
with an undefined function (11). The X-zone degenerates during the first pregnancy of 
female mice, disappearing by the 12th day of gestation, and by puberty in male mice. In the 
absence of pregnancy, the X-zone nonetheless degenerates in females but slowly over a 




notably higher weight and total volume of the cortex and medulla than those of males from 65 
the age of 5 weeks that is maintained into adulthood (12). 
In humans, the final three steps in the biosynthesis of aldosterone involve the 
conversion of deoxycorticosterone by the successive action of the 11β-hydroxylase, 18-
hydroxylase and 18-methyloxidase activities of a single enzyme, aldosterone synthase, 
encoded by CYP11B2 (9, 10). An 11β-hydroxylase in the zF, encoded by a distinct but highly 70 
homologous gene to CYP11B2 called CYP11B1, converts 11-deoxycortisol to cortisol. 
Humans, mice, rats, hamsters, guinea pigs and monkeys express two CYP11B enzymes 
whereas cows, sheep, horses, pigs and dogs express a single CYP11B enzyme that catalyzes 
the final step/s in the synthesis of both cortisol and aldosterone (13-18) (Table 1). Despite 
the presence of a single CYP11B in these species, functional zonation with aldosterone 75 
production in the zG and cortisol synthesis in the zF is maintained by an unknown 
mechanism, which presumably involves the presence of zone-specific factors that modulate 
CYP11B activity.  
Regulation of aldosterone synthesis in humans and other species 
The principal function of aldosterone is to maintain fluid and electrolyte balance 80 
promoting Na+ retention and K+ secretion in the distal nephron of the kidney, thereby 
controlling blood pressure (10). In zG cells, angiotensin II (Ang II) stimulates phospholipase C 
and triggers inositol triphosphate-dependent Ca2+ release from the endoplasmic reticulum, 
whilst high plasma K+ concentrations or long-term stimulation by Ang II results in membrane 
depolarization and the activation of L- and T-type Ca2+ channels (19). The increase in 85 
intracellular Ca2+ leads to an increase in expression of the aldosterone synthase gene 
(CYP11B2) and aldosterone production (17). Small changes in plasma K+, as low as 1 mM, can 




conductance with a membrane potential close to the K+ equilibrium potential. At low plasma 
K+ concentrations the membrane voltage is hyperpolarized and small increases in K+ are 90 
sufficient to slightly depolarize the membrane and activate T-type Ca2+ channels (21-23). 
Therefore, mechanisms that regulate the membrane potential of the zG cell play a crucial 
role in the control of aldosterone production and usually depend on the equilibrium 
potential and ion conductance across the plasma membrane.  
The negative membrane voltage is mainly determined by 2-pore domain K+ channels, 95 
the TASK channels (TWIK-related acid sensitive K+ channels or K+-selective leak channels), 
that generate the aforementioned background or “leak” K+ currents. K+ inwardly rectifying 
channels (called G protein activated inwardly rectifying K+ channels, GIRK) also regulate the 
membrane potential of zG cells and GIRK4 (encoded by KCNJ5) may function in normal 
adrenal physiology in addition to its pathological role in aldosterone production via gain-of-100 
function mutations as described above.  
Different species employ different K+ channels to maintain the membrane potential 
of the zG cell (24) and distinct differences between species have been reported for the 
expression of some key K+ channels (25). TASK-1 is expressed in the zG and zF in both 
humans and rats. TASK3 is localized to the zG in the human and rat adrenal with high 105 
expression in the rat and low expression in the human (25). GIRK4 (KCNJ5) is strongly 
expressed in the zG of the human adrenal but is undetectable in the rat zG and zF (25). Thus 
the distinct expression patterns of K+ channels between species suggests an evolutionary 
divergence in the regulation of aldosterone production and indicates that rats and probably 






Mouse models of primary aldosteronism 
Several genetically modified mouse models of hyperaldosteronism have been 
reported that display the main biochemical features of PA but do not reproduce the adrenal 115 
tumourigenesis or hyperplasia associated with this condition. Mouse models of 
hyperaldosteronism are discussed further below and are summarized in Table 2. 
Mouse models with deletions of TASK channels 
Electrophysiological recordings of zG cells have emphasized the importance of leak-
type K+ channels of the 2-pore domain family in conferring background K+ conductance. In 120 
rodents, two members of the 2-pore domain family, Task1 (Kcnk3) and Task3 (Kcnk9) are the 
dominant leak-type channels. Female mice with the Task1 gene deleted display 
hyperaldosteronism with low plasma renin activity and a decrease in plasma K+. Systolic 
blood pressure is increased and responds to administration of a mineralocorticoid receptor 
antagonist (26). The Cyp11b2 gene is expressed aberrantly exclusively in the zF and the 125 
elevated aldosterone is suppressed by dexamethasone (26). Male Task1-/- mice and 
heterozygous females do not exhibit a phenotype. Mice of both sexes at postnatal day 18 
exhibit an abnormal distribution of the Cyp11b2 enzyme. Castrated male Task1-/- display an 
abnormal expression of Cyp11b2, similar to females, and estradiol administration decreases 
the level of Cyp11b2 expression, but not the zonal distribution. Female Task1-/- injected with 130 
testosterone display a normal zonation indicating the role of androgens (26).    
Gene expression analysis of the adrenals of male and female Task1-/- revealed a 
limited number of differentially expressed genes, mostly involved in signaling cascades, and 
one of these belongs to the dickkopf family, Dkk3, that is expressed in the zG of the adrenal 




Task1-/-  extended the hyperaldosteronism phenotype to male mice. The zonal distribution of 
the double deleted of Dkk3-/- and Task1-/-  was preserved in contrast to female Task1-/-  mice. 
TASK1 (KCNK3) is expressed in both mouse and human adrenals. In the human 
adrenocortical NCI H295R cell line, downregulation of TASK1 by a siRNA increased 
aldosterone production (28). Genome-wide association studies have identified KCNK3 single-140 
nucleotide polymorphism (SNP) variants associated with blood pressure in humans (29). The 
KCNK3 SNP (rs1275988) is associated with hypertension in African-Americans and a nearby 
SNP (rs13394970) is associated with hypertension in Hispanics, which was found in the 
MESA (Multi-Ethnic Study of Atherosclerosis) that comprised 7,840 individuals. Aldosterone 
levels and plasma renin activity in a subset of 1,653 participants were also found associated 145 
with KCNK3 rs2586886 (29). The functional significance of these SNPs on channel function is 
unknown and while in the mouse complete deletion of Kcnk3 in females is required for the 
phenotype, an alteration determined by a polymorphism is of unknown significance in 
humans. 
Gene deletion of both the Task1 and Task3 in male mice ablates background K+ 150 
currents resulting in marked depolarization of the membrane potential in zG cells (30). 
Task1-/-, Task3-/- mice excrete higher urinary aldosterone at all levels of sodium intake. The 
mice also have normal or low renin activity and aldosterone production fails to normalize on 
high sodium intake or after the administration of the angiotensin receptor blocker 
candesartan (30). Adrenal zonation is unaltered and Task1-/-, Task3-/- mice may represent a 155 
model of idiopathic primary aldosteronism.  
Task3-/- mice display mild aldosterone overproduction, a decreased plasma renin 
concentration and fail to suppress aldosterone excretion on a high sodium diet. These mice 




potential of zG cells was not different from that of wild type mice, even though the mice 160 
were slightly hypokalemic. Although there was a small increase in Cyp11b2 mRNA, there was 
no increase in aldosterone synthase expression. A recent study indicates that TASK3 is not 
located in the plasma membrane, but is located in the mitochondrial membrane and plays a 
role in mitochondrial membrane potential (33). It has been suggested that the lack of plasma 
membrane depolarization, unchanged expression of the Cyp11b2 protein, but increased 165 
production of aldosterone might result from an increase in the activity of the late pathway 
of aldosterone biosynthesis (34) (conversion of deoxycorticosterone to aldosterone in the 
mitochondria). Neonatal Task3-/- mice display a severe phenotype with a strong increase in 
plasma aldosterone, corticosterone and progesterone that decreases with age (35) with a 
significant increase in Cyp11b2 mRNA for the neonatal mice that normalizes in adults. There 170 
is a marked increase in adrenal renin expression and concentration mainly in the zF that 
decreases with age (35).   
Mouse models with deletions of large Ca2+ activated K+ channel subunit deletions  
Large Ca2+-activating K+ channels (BK) are composed of an α pore (BKα) and one to 
four β subunits. There are multiple splice variants of BKα and the cell-specific function of BK 175 
channels is determined by the BKα splice variant in association with one of the four β 
subunits (36). Under normal conditions, the BKα/β1 channel opens in response to local 
elevations in intracellular Ca2+ (Ca2+ sparks) leading to a compensatory vasorelaxation, but in 
a study performed with the BKβ1 gene inactivated (Kcnmb1-/-) in male mice, channel activity 
is uncoupled from Ca2+ sparks leading to hypertension (37). The BKβ-/- mice retain fluid, 180 
which is enhanced on a high K+ diet and administration of the mineralocorticoid receptor 




(37-38). Plasma aldosterone concentrations are increased and exacerbated by K+ loading as 
the adrenal is highly sensitive to K+ retention by the renal connecting tubules of the BKβ1−/− 
mice (37). The increased aldosterone secretion is due to an increased sensitivity of the zG to 185 
K+ (37). While BKα is highly expressed in the zG and weakly in the adrenal medulla, BKβ1 
appears to be expressed in the medulla only (37, 39). In the adrenal medulla BKα/β may 
function in hyperpolarizing the membrane potential of chromaffin cells to inhibit Ca2+-
mediated catecholamine release, analogous to the role of this channel in other tissues. In zG 
cells, catecholamines induce increases in cAMP levels that have been demonstrated to 190 
stimulate Ca2+ influx via L-type Ca2+ channels (40), a known pathway leading to increased 
aldosterone production. The hypertension in the BKβ1-/- model is due to both the elevation 
of aldosterone levels and the abnormal vasorelaxation of the vascular smooth muscle cells.  
Gene deletion of the BKα  (Kcnma1-/-) resulted in a small, but significant increase in 
blood pressure with normal heart rate, a gender-independent decrease in plasma K+ 195 
concentration and an elevation of plasma aldosterone with normal renin or serum 
corticotropin levels (39). The elevation of the blood pressure was due to the 
hyperaldosteronism and the vascular dysfunction that resulted from the gene deletion. 
Transgenic mouse models with constitutively activated β-catenin 
The Wnt/β-catenin signaling is essential for embryonic development and cell 200 
proliferation, but constitutive activation is associated with a variety of cancers (41). In the 
absence of extracellular Wnt ligands, the N-terminal domain of β-catenin is phosphorylated 
on serines/threonine residues by a multi protein destruction complex composed of casein 
kinase I, glycogen synthase kinase 3β, axin and APC (adenomatous polyposis coli), which 




(lipoprotein receptor-related protein) receptor inhibits the destruction complex and β-
catenin is stabilized and undergoes nuclear translocation and activation of LEF/TCF (T-cell 
factor/lymphoid enhancer factor) transcription factors resulting in increased gene 
expression (42).  
β-catenin plays a role in adrenal development (43) and activated β-catenin has been 210 
shown to occur in adrenal cortical carcinomas and adenomas (41) and activating mutations 
of β-catenin are found in some human aldosterone-producing adenomas (44). Transgenic 
mice with an adrenal-restricted constitutive activation of β-catenin (∆Cat) display adrenal 
hyperplasia and dysplasia that produces profound changes in zonal identity and causes 
hyperaldosteronism in females with some of the mice also developing adrenal cancers at 17 215 
months of age (45).  Disease progression was slow in male ∆Cat mice and the study was 
largely performed in females; however, males also displayed adrenal hyperplasia but no 
signs of malignancy. 
Transgenic mouse models with a truncated form of adenomatous polyposis coli 
As described above, APC is a component of the destruction complex of β-catenin. 220 
Mice that express a defective mutant of Apc, which lacks the C-terminal portion of the gene 
(apcMin/+), develop multiple intestinal tumors (46). These mice also exhibit hypertension with 
an increase in plasma volume, a marked increase in fractional urinary excretion of K+, a 
decrease in urinary Na+ excretion and an increase in plasma aldosterone and corticosterone 
concentrations (47).  225 
The aldosterone-responsive SGK1 (serum/glucocorticoid regulated kinase 1) is also 
stimulated by β-catenin; therefore, stabilization of β-catenin would be expected to 




expression of cell surface epithelial Na+ channels (ENaC) that function in the regulation of 
Na+ and fluid reabsorption in the kidney and colon (48, 49). ApcMin/+/sgk-/- mice display 230 
increased aldosterone but not corticosterone levels compared to apcMin/+ mice, and the 
hypertension of apcMin/+  mice is ablated in the double transgenic model (47). This effect is 
attributed to the impaired Na+ retention determined by the sgk deletion whereas 
aldosterone secretion is directly affected by Apc-dependent signaling (47). This suggests that 
the apcMin/+ mice are a model of primary aldosteronism whereas the double apcMin/+/sgk-/- 235 
transgenic model is a model of both primary and secondary aldosteronism. The 
normalization of hypertension by deletion of the sgk gene likely reflects the role of Sgk in 
ENaC expression. The above study on apcMin/+ and apcMin/+/sgk-/- mice was performed using 
sex-matched mice of 3 months of age. No gender-related phenotype differences were 
reported. 240 
The potential relevance of APC variants in some patients with PA is indicated by a 
case report of a young patient with severe hypertension and PA in a background of familial 
adenomatous polyposis with a germline heterozygous APC mutation (50). The patient 
displayed bilateral macronodular adrenal hyperplasia with lateralized aldosterone secretion. 
Molecular analysis and histopathology of the resected adrenal showed 3 nodules with one 245 
expressing CYP11B2 and carrying a somatic KCNJ5 mutation. This nodule and an additional 
nodule had a somatic biallelic APC inactivation that potentially triggered cell proliferation, 







Mouse models with deletion of cryptochrome-1 and cryptochrome-2 
Behaviour, metabolism and physiology are subject to a well-controlled daily rhythm 
regulated by a molecular oscillator called the circadian clock. Alteration of the circadian 
rhythm in shift workers, flight crews and individuals with sleep disorders have a higher than 255 
average incidence of cardiovascular disorders (51). Disruption of the circadian clock in Cry-
null mice that lack the core clock components cryptochrome-1 and cryptochrome-2 (Cry1-/-
/Cry2-/-) results in hyperaldosteronism with salt-sensitive hypertension and renal damage 
(53-54). Age- and gender-related variations were eliminated by the inclusion of only male 
mice aged 12 to 16 weeks. The hyperaldosteronism is reportedly due to dysregulation of the 260 
3β-hydroxysteroid dehydrogenase b6 (Hsd3b6) which is overexpressed in the zG of the 
mouse adrenal. The expression of the aldosterone synthase is unchanged and it is believed 
that overexpression of the Hsd3b6 allows further substrate to become available for the 
synthesis of aldosterone (52-53). The Hsd3b6 homolog in humans is the HSD3B1 isozyme 
which is expressed in the zG of the human adrenal (54).   265 
Period 1 (Per1) is another core component of the circadian clock and Per1 and Cry2 
can mediate opposing effects on target genes (55). Mice with reduced Per1 levels in vivo 
display decreased plasma aldosterone concentrations and a reduction in Hsd3b6 expression 
(56). This may be accounted for by an increase in Cry2 expression as Per1 levels decrease 
that causes a dysregulation of Hsd3b6 gene expression. 270 
Mouse models with differential levels of transforming growth factor β1 expression 
Polymorphisms of the TGFB1 gene located in the sequence coding the signal peptide 
are associated with a reduced risk of hypertension in a European population (57) and a 




associated with hypertension in an Asian population (58). The 3‘-untranslated region of the 275 
Tgfb1 gene was manipulated to increase or decrease the stability of the encoded mRNA. 
Male mice were then created to express Tgfb1 in five grades from 10-300% that of normal. 
Plasma aldosterone and corticosterone concentrations increased as Tgfb1 gene expression 
levels decreased. Mice with the lowest Tgfb1 expression (Tgfb1L/L) had approximately 200% 
higher plasma aldosterone and corticosterone concentrations compared with wild type, 280 
whereas the plasma aldosterone concentration of mice with the highest expression of Tgfb1 
(Tgfb1H/H) was approximately halved. Expression of Cyp11b2 and Cyp11b1 followed the 
changes in Tgfb1 expression as predicted. The animals with decreased Tgfb1 had higher 
plasma volumes and elevated blood pressure and lower levels of angiotensin II (59) and the 
hypertension was corrected with spironolactone. 285 
Mouse models produced using a random mutagenesis screen 
In attempt to find novel genetic loci associated with primary aldosteronism, a large-
scale mutation screen was performed in mice injected with N-ethyl-N-nitrosourea (ENU, an 
alkylating agent that causes ethylation of nucleic acids resulting in point mutations) to 
randomly introduce mutations into the mouse genome (60). As expected, the resulting 290 
mutagenesis caused a phenotypic spectrum from total loss-of-function of some genes to 
gain-of-function and generated mouse lines with elevated plasma aldosterone 
concentrations in males but not in females. Exome next generation sequencing identified 8 
mutated genes that were common between the F1 and F5 generations of the mice with high 
plasma aldosterone concentrations. Although animals carry more than one mutated gene, 295 
an attempt was made to correlate the expression of mutated genes with aldosterone levels 
and animals carrying mutations in the Sspo, Dguok, Hoxaas2 and Clstn3 genes displayed 




adenomas or hyperplasia, but exhibited an increased staining for the Cyp11b2 enzyme that 
was more pronounced in the middle and inner areas of the adrenal cortex compared to wild 300 
type animals suggesting an altered zonation of Cyp11b2. Further studies will be necessary to 
characterize each individual gene in the regulation of aldosterone. 
Mouse models with an increased expression of the aldosterone synthase gene 
The biosynthesis of aldosterone depends on the transcriptionally regulated last 
enzyme in the pathway, aldosterone synthase (CYP11B2) (19). Male and female mice were 305 
generated with increased stability of the Cyp11b2 mRNA by substitution of the 3’ 
untranslated region with the more stable 3‘ untranslated sequence of the bovine growth 
hormone mRNA (62). Cyp11b2hi/hi mice displayed a slight increase in Cyp11b2 mRNA 
expression on a normal sodium diet with normal plasma aldosterone concentrations that 
were higher than those of wild type animals on a high sodium diet (62). The Cyp11b2hi/hi 310 
mice on a modest high salt diet infused with Ang II had a higher blood pressure, cardiac 
hypertrophy and oxidative stress than wild type animals (62). There were no reported 
phenotype differences related to gender. The modest elevation of aldosterone synthase 
expression in humans could result in the development of hypertension in societies that 
consume a high sodium diet. 315 
Transgenic mice were produced with the promoter region of the human CYP11B1 
gene fused to the coding region of the human CYP11B2 gene (63). The heterozygous mice 
called hAS+/-  were shown to be hyperaldosteronemic, hypertensive when administered a 
high salt diet and as expected the plasma K+ was lower and Na+ higher than the wild type 
mice. The high salt induced hypertension was normalized by the administration of fadrozole, 320 
an aldosterone synthase inhibitor. These mice could be useful for the study of the 




Perspectives and Conclusions 
Mouse models of human disease often fail to represent the whole clinical spectrum. 
Although several mouse models of hyperaldosteronism have been described over recent 325 
years, they have not reproduced a genetic alteration shown to cause PA in humans and do 
not display the tumour formation or hyperplasia that reflect the pathophysiology of this 
disease. These models are however valuable to study mechanisms of fluid and electrolyte 
homeostasis and the regulation of aldosterone production as well as providing potential 
targets for the pharmacological treatment of conditions where aldosterone production is 330 
elevated as in PA. 
Humans and rodents display some notable differences in adrenal physiology with 
alternative patterns of adrenal steroid production and distinct differences in the expression 
of K+ channels that maintain the membrane potential of zG cells. This divergence 
underscores the dubious suitability of available mouse models to resemble human 335 
pathophysiology. Further refined mouse models with inducible, zone specific introduction of 
point mutations that have been observed in human disease could represent one possible 
approach to fill this gap. Furthermore, the adrenal physiology of larger animals such as pigs, 
that are useful to model complex disease traits, could also resemble more closely that of 
humans and may offer the possibility to recapitulate genetic hits in ion pumps and channels 340 
that have been shown to cause the human disorder. Yet pigs express a single CYP11B 
enzyme for aldosterone and cortisol synthesis instead of the two enzymes expressed in 
humans (CYP11B2 and CYP11B1). Notwithstanding this complexity, the sequencing of the pig 
genome by the Swine Genome Sequencing Project, and advances in genome editing 




expressing human CYP11B1 and CYP11B2 to provide data that can be translated to the 
human condition. 
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Figure legend 545 
Cholesterol is mobilised from a store in the outer mitochondrial membrane (OMM) and is 
transferred by steroidogenic acute regulatory protein (StAR) to the inner mitochondrial 
membrane (IMM) where it is converted to pregnenolone by P450scc, the first and rate-
limiting step of steroidogenesis (9, 10). Aldosterone biosynthesis is restricted to the zona 
glomerulosa (zG) where aldosterone synthase is localized. In humans, the activity of 17α-550 
hydroxylase/17,20 lyase (17αOHase, CYP17A1) is a key enzyme for the synthesis of both 
cortisol and androgens; the main biosynthetic pathway for cortisol synthesis is via the 17α-
hydroxylation of pregnenolone, indicated by thicker arrows (panel A). Mice, like other 
rodents, do not express CYP17A1 and as a result the major glucocorticoid synthesised is 
corticosterone (instead of cortisol) that is produced from deoxycorticosterone by 11β-555 
hydroxylase (11βOHase, Cyp11b1) in the zona fasciculata (zF) (panel B). The absence of 
CYP17A1 expression in mice means that adrenal androgens cannot be synthesised as in 
humans in the zona reticularis (zR) and mice do not have a distinguishable zR (panels A and 
B). Young mice have an X-zone that degenerates by the first pregnancy in females and by 
sexual maturity in males. 3βHSD, 3β-hydroxysteroid dehydrogenase; 21OHase, 21-560 
hydroxylase; Aldo synthase, aldosterone synthase; 17αOHase, 17α-hydroxylase; STS, steroid 
sulfatase; DHEAS, dehydroepiandrosterone sulfate. Including data from Stowasser M & 
Gordon RD (10). 
